Welcome to Multibagg AI
Log in to access personalized features
Discovery themes featuring this stock
Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
Investor Presentation
Q2 FY26
Investor Presentation
Q4 FY25
Investor Presentation
Q2 FY25
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q4 FY24
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q3 FY24
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Home
Dashboard
Ask Iris
Discovery
Timeline
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Maitreya Medicare Ltd (MAITREYA) is currently trading at N/A per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Maitreya Medicare Limited is a multi-specialty hospital established in 2019, based in Surat, Gujarat, with a focus on diverse healthcare services across 18 specialties including cardiology and neurology. The company has pursued aggressive capacity expansion, establishing new units and partnerships across Gujarat and Maharashtra to broaden their service delivery and patient reach, despite incurring short-term costs. Government-backed schemes and strategic partnerships with facilities like KLS Memorial Hospital in Mumbai enhance Maitreya Medicare's market presence and operational capabilities. Despite a current Phase of profit challenges due to strategic investments, Maitreya retains a transparent financial approach, ensuring stakeholders are aware of its growth intentions and long-term strategies.
Over the past 52 weeks, Maitreya Medicare Ltd has traded between a low of ₹NaN and a high of ₹NaN. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Maitreya Medicare Ltd has a market capitalization of approximately 155.27. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Maitreya Medicare Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 26.07 and operates in the Healthcare sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 155.27 Cr, Maitreya Medicare Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Maitreya Medicare Ltd operates in the Healthcare sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Maitreya Medicare Ltd is 26.07. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
Bearish
0
Neutral
14
Bullish
0
Bearish
0
Neutral
46
Bullish
0
Bearish
0
Neutral
32
Bullish
0
| Symbol | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
109.50 | 226 Cr | 365.91 | 3.73 | 0.00 | 1.11 | 2.57 | 0.91 | |
74.50 | 174 Cr | 53.21 | 1.75 | 0.00 | 1.13 | 2.34 | 2.08 | |
229.15 | 155 Cr | 26.07 | 5.81 | 0.00 | 0.52 | 4.98 | 0.33 | |
66.80 | 110 Cr | 28.07 | 2.06 | 0.00 | 6.13 | 8.59 | 5.07 | |
51.75 | 97 Cr | 21.30 | 2.82 | 0.00 | 13.19 | 14.48 | 12.21 | |
59.50 | 84 Cr | 9.71 | 1.68 | 0.00 | 0.00 | 0.00 | -1.10 |
Maitreya Medicare Limited is a multi-specialty hospital established in 2019, based in Surat, Gujarat, with a focus on diverse healthcare services across 18 specialties including cardiology and neurology.
The company has pursued aggressive capacity expansion, establishing new units and partnerships across Gujarat and Maharashtra to broaden their service delivery and patient reach, despite incurring short-term costs.
Government-backed schemes and strategic partnerships with facilities like KLS Memorial Hospital in Mumbai enhance Maitreya Medicare's market presence and operational capabilities.
Despite a current Phase of profit challenges due to strategic investments, Maitreya retains a transparent financial approach, ensuring stakeholders are aware of its growth intentions and long-term strategies.
Healthcare
Hospitals / Medical Services
155 Cr
Low Risk
26.1
60.0
1.2
5.8
329.00
178.60
Sales CAGR
Profit CAGR
ROE
ROCE
